Mastodon

Enzystal® (Tablets) Instructions for Use

Marketing Authorization Holder

Torrent Pharmaceuticals, Ltd. (India)

ATC Code

A09AA02 (Polyenzyme preparations (incl. lipase, protease))

Active Substances

Pancreatin (BAN)

Hemicellulase (Group)

Bile (Group)

Dosage Form

Bottle OTC Icon Enzystal® Enteric-coated tablets: 4, 6, 20, 80 or 100 pcs.

Dosage Form, Packaging, and Composition

Enteric-coated tablets white, round, biconvex.

1 tab.
Pancreatin 192 mg
   With minimum enzymatic activity
   Lipases 6000 FIP U
   Amylases 4500 FIP U
   Protease 300 FIP U
Ox bile extract 25 mg
Hemicellulase 50 mg

4 pcs. – blisters (1) – cardboard packs.
6 pcs. – blisters (1) – cardboard packs.
10 pcs. – blisters (2) – cardboard packs.
10 pcs. – blisters (8) – cardboard packs.
4 pcs. – strips (1) – cardboard packs.
6 pcs. – strips (1) – cardboard packs.
10 pcs. – strips (10) – cardboard packs.

Clinical-Pharmacological Group

Enzyme preparation

Pharmacotherapeutic Group

Digestive enzyme agent

Pharmacological Action

A combined medicinal product, the action of which is due to the components that make up its composition. It has proteolytic, amylolytic, and lipolytic action.

It promotes rapid and complete digestion of food, eliminates symptoms arising from digestive disorders (feeling of heaviness and fullness in the stomach, flatulence, feeling of lack of air, shortness of breath caused by gas accumulation in the intestines, diarrhea).

It improves the process of food digestion in children; stimulates the secretion of the body’s own enzymes of the pancreas, stomach, and small intestine, as well as bile.

Bile extract acts choleretically, promotes fat emulsification, increases the activity of Lipases, improves the absorption of fats and fat-soluble vitamins A, E, K.

Hemicellulase is an enzyme that promotes the breakdown of plant fiber.

Indications

Exocrine insufficiency of the pancreas, stomach, intestines, liver, gallbladder (chronic inflammatory-dystrophic diseases of these organs, condition after resection or irradiation); flatulence, diarrhea of non-infectious origin; cystic fibrosis.

To improve food digestion in persons with normal gastrointestinal function in case of dietary errors (consumption of fatty foods, large amounts of food, irregular meals); in cases of chewing function impairment (damage to teeth and gums, during the period of adaptation to an artificial jaw); sedentary lifestyle; prolonged immobilization.

Preparation for X-ray examination and ultrasound of the abdominal organs. As an auxiliary medicinal product for faster absorption of certain medicinal products (PAS, sulfonamides, antibiotics).

ICD codes

ICD-10 code Indication
E84 Cystic fibrosis
K29 Gastritis and duodenitis
K30 Functional dyspepsia (digestive disorder)
K52.9 Noninfective gastroenteritis and colitis, unspecified
K59.1 Functional diarrhea
K81.1 Chronic cholecystitis
K86.1 Other chronic pancreatitis
K86.8 Other specified diseases of pancreas (atrophy, calculi, cirrhosis, fibrosis of pancreas)
K90.3 Pancreatic steatorrhea
K91.1 Postgastric surgery syndromes
K91.2 Postprocedural malabsorption, not elsewhere classified
K91.5 Postcholecystectomy syndrome
R14 Flatulence and related conditions (including abdominal bloating, belching)
Z51.4 Preparatory procedures for subsequent treatment or examination, not elsewhere classified
Z72.4 Inappropriate diet and harmful eating habits
ICD-11 code Indication
CA25.Z Cystic fibrosis, unspecified
DA42.Z Gastritis, unspecified
DA51.Z Duodenitis, unspecified
DA7Z Diseases of stomach or duodenum, unspecified
DA90.0 Syndromic diarrhea
DA96.0Y Other specified intestinal malabsorption
DC12.1 Chronic cholecystitis
DC14.1 Postcholecystectomy syndrome
DC32.0 Calcific pancreatitis
DC32.1 Paraduodenal pancreatitis
DC32.2 Hereditary chronic pancreatitis
DC32.4 Chronic idiopathic pancreatitis
DC32.5 Tropical pancreatitis
DC32.Z Chronic pancreatitis, unspecified
DC33 Autoimmune pancreatitis
DC34 Obstructive pancreatitis
DC35.2 Pancreatic steatorrhea
DC35.Z Other specified diseases of pancreas, unspecified
DC3Z Diseases of pancreas, unspecified
DD90.0 Globus sensation
DD90.1 Functional dysphagia
DD90.3 Functional dyspepsia
DD90.Z Functional disorders of esophagus or gastroduodenal system, unspecified
DD91.2 Functional diarrhea
DD93.Y Other specified functional gastrointestinal disorders in infants, toddlers and school-age children
DD9Z Functional gastrointestinal disorders, unspecified
DE11 Dumping syndrome
DE2Z Diseases of the digestive system, unspecified
ME08 Flatulence and related conditions
QB9A Preparatory procedures for subsequent treatment
QE23 Problems with inappropriate nutrition or eating habits

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Orally, 1 single dose 3 times/day during or immediately after meals. Swallow whole, do not chew. If necessary, the single dose can be doubled.

The duration of treatment ranges from several days (in case of digestive disorders due to dietary errors) to several months and years (if constant replacement therapy is necessary).

Before X-ray examination and ultrasound – 2 single doses 2-3 times/day for 2-3 days before the examination.

Adverse Reactions

Allergic reactions skin hyperemia, sneezing, lacrimation.

From the digestive system diarrhea, nausea, abdominal pain (including intestinal colic). In children (when taken in high doses) – perianal irritation, irritation of the oral mucosa.

From metabolism hyperuricemia, hyperuricouria.

Contraindications

Hypersensitivity; hyperbilirubinemia; acute pancreatitis, chronic pancreatitis (exacerbation), hepatitis, hepatic insufficiency, hepatic coma or precoma, gallbladder empyema, cholelithiasis, mechanical jaundice, intestinal obstruction.

With caution cystic fibrosis, pregnancy; children’s age (under 3 years).

Use in Pregnancy and Lactation

With caution: pregnancy.

Use in Hepatic Impairment

Contraindicated in hepatitis, hepatic insufficiency, hepatic coma or precoma.

Pediatric Use

With caution: children’s age (under 3 years).

Drug Interactions

Reduces the bioavailability of iron preparations.

Increases the absorption of PAS, sulfonamides, antibiotics.

Cimetidine enhances the effect of the drug.

Antacids containing magnesium and/or calcium ions reduce the effectiveness of the drug.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS